62.21 USD
↗ 0.88 (1.44%)LIVE (AS OF 03:44 PM EDT)
Royalty Pharma plc Class A Ordinary Shares
RPRXNASDAQ • USD
Market: OPEN
Royalty Pharma plc Class A Ordinary Shares (RPRX) is currently trading at $62.21. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 24, 2026.
Open?$61.33
High?$62.45
Low?$60.92
Prev. Close?$61.33
Volume?1.1M
Avg. Volume?2.8M
VWAP?$61.96
Rel. Volume?0.40x
Bid / Ask
Bid?$62.23 × 600
Ask?$62.26 × 100
Spread?$0.03
Midpoint?$62.25
Valuation & Ratios
Market Cap?27.3B
Shares Out?445.3M
Float?435.9M
Float %?98.3%
P/E Ratio?33.51
P/B Ratio?4.00
EPS?$1.83
Dividend?2.73%
Ex-Dividend?N/A
News
Profile
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
Themes
Employees
100
Market Cap
27.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-06-16
Address
110 EAST 59TH STREET
NEW YORK, NY 10022
Phone: (212) 883-0200
NEW YORK, NY 10022
Phone: (212) 883-0200
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?45
Momentum?73
Short Sent.?63
Piotroski F-Score?4/9Mixed
Altman Z-Score?2.25Grey
Confidence?76%Moderate
Short InterestModerate
Short % of Float?2.45%Low
Short Interest?10.7M
Days to Cover?4.1
Free Float435.9M
Avg Daily Volume2.6M
Settlement Date2026-07-31
Financial Health
Current Ratio?2.80Strong
Quick Ratio?2.80Strong
Cash Ratio?1.29Strong
Debt/Equity?1.33Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?33.5PRICEY▾
Peers100
S&P25
P/B?4.00FAIR▾
Peers100
S&P44
P/S?10.77HIGH▾
Peers100
S&P7
P/FCF?9.2CHEAP▾
Peers100
S&P91
EV/EBITDA?20.7HIGH▾
Peers100
S&P23
EV/Sales?14.02HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?11.9%FAIR▾
Peers50
S&P43
ROA?4.1%FAIR▾
Peers50
S&P37
Cash Flow & Enterprise
FCF?$3.0B
Enterprise Value?$35.6B
Fundamentals ratios updated end of day